Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy

Published:1997-10 Issue:8 Volume:76 Page:1099-1105
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cameron DA,Anderson EDC,Levack P,Hawkins RA,Anderson TJ,Leonard RCF,Forrest APM,Chetty U

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc1997514.pdf

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study;Chinese Journal of Cancer Research;2024

2. The Effects of Technology Innovativeness and Sensational Seeking on Therapeutic Metaverse Behavior;Korean Journal of Human Ecology;2023-04-30

3. Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies;Cancers;2022-06-18

4. Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes;European Radiology;2022-01-06

5. Breast cancer;Journal of Modern Oncology;2021-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP